September 2020
172 articles-
Sep 30 · 07:46Biotechnology Daily
LabCorp aims to take Genfit's NASH liver diagnostic blood test into primary care
-
Sep 30 · 07:45Biotechnology Daily
AI drug designer XtalPi raises $318M from SoftBank, Tencent, others for 'digital twin' simulation efforts
-
Sep 30 · 07:42Biotechnology Daily
Dewpoint Therapeutics to put 'pedal to the metal' with $77M round
-
Sep 30 · 07:33Biotechnology Daily
Killing cancer by blocking cell doors
-
Sep 30 · 07:30Bio Business News
South Korean exosome biotech Ilias Biologics nabs $20M B round
-
Sep 30 · 07:23Bio Business News
BridgeBio's en route to proving out its 'Moneyball' for biotech model: CEO
-
Sep 30 · 07:20Bio Business News
TriSalus hires Katz to run studies of ex-Dynavax cancer drug
-
Sep 30 · 07:00Market Watch
Micron stock slides as weak outlook follows doubled earnings
-
Sep 30 · 06:57Market Watch
Facebook Inc. Cl A stock outperforms competitors on strong trading day
-
Sep 30 · 06:54Market Watch
European stocks choppy and U.S. equity futures fall after chaotic presidential debate
-
Sep 29 · 06:15Biotechnology Daily
FDA gives OK for home use of CapsoVision's endoscopic camera pill
-
Sep 29 · 06:14Biotechnology Daily
Implant system maker Spinal Elements files for $100M Nasdaq IPO
-
Sep 29 · 06:08Biotechnology Daily
Philips launches small, push-button blood clot removal system
-
Sep 29 · 06:06Bio Business News
Palladio grabs $20M to take once-discarded drug through phase 3
-
Sep 29 · 05:59Bio Business News
Galecto bags $64M to push lung fibrosis med toward EU nod
-
Sep 29 · 05:44Market Watch
Bank of America Corp. stock rises Monday, outperforms market
-
Sep 29 · 05:42Market Watch
Dow ends 410 points higher, stocks rally ahead of presidential debate and Friday’s jobs report
-
Sep 29 · 05:35Market Watch
Apple Inc. stock rises Monday, outperforms market
-
Sep 28 · 00:26Biotechnology Daily
New atlas of the human heart could guide personalized medicine in cardiology
-
Sep 28 · 00:23Biotechnology Daily
Poxel posts phase 3 diabetes data ahead of approval decision
-
Sep 28 · 00:18Biotechnology Daily
Novo Nordisk tees up phase 3 trial for once-weekly insulin
-
Sep 28 · 00:12Bio Business News
Flagship's Valo emerges with $100M and plans to transform R&D
-
Sep 28 · 00:10Bio Business News
Looking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO
-
Sep 28 · 00:04Bio Business News
Babson Diagnostics nets new CEO, plus $13.7M for its blood test devices